Literature DB >> 4451752

Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.

R G Pertwee.   

Abstract

1 Three injections of cannabis extract (500 mg/kg s.c. given over 3 or 5 days) diminished thymus gland weight but not the weights of spleen or liver in weanling female and adult male mice kept at room temperature.2 Both cannabis extract (500 mg/kg s.c.) and Delta(1)-tetrahydrocannabinol (Delta(1)-THC; 10 and 20 mg/kg i.p.) elevated corticosterone levels in mouse plasma.3 A pretreatment that consisted of three daily subcutaneous injections of 500 mg/kg of cannabis extract and that was shown to produce tolerance to the ;cataleptic' effect of Delta(1)-THC (2 mg/kg i.v.) in mice, also produced tolerance to the effect of Delta(1)-THC (10 mg/kg i.p.) on corticosterone levels in mouse plasma. However, this pretreatment did not reduce the rise in plasma corticosterone concentration produced by immobilization.4 Tolerance to the effect of Delta(1)-THC (10 mg/kg i.p.) on corticosterone levels in mouse plasma was also produced by the pretreatment of mice with a single injection of Delta(1)-THC (10 mg/kg s.c.). Three daily injections of Delta(1)-THC (10 or 30 mg/kg s.c.) also produced tolerance.5 In a thermoneutral environment (30-32 degrees C) in which cannabis extract does not produce hypothermia, the drug no longer reduced thymus gland weight. However the effect of cannabis extract and of Delta(1)-THC on corticosterone plasma levels was the same at room temperature as at 30-32 degrees C. Tolerance to the latter effect of Delta(1)-THC was also produced equally readily under the two conditions.6 It is concluded that pretreatment with cannabis extract or Delta(1)-THC can produce tolerance to the effect of Delta(1)-THC on corticosterone levels in mouse plasma and does so without impairing the effect of immobilization stress on corticosterone release. In addition, both the rise in corticosterone plasma levels produced by cannabis or Delta(1)-THC and the development of tolerance to this effect can still take place in the absence of hypothermia.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451752      PMCID: PMC1776781          DOI: 10.1111/j.1476-5381.1974.tb10674.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Phase relations of 24-hour periodicities in blood corticosterone, mitoses in cortical adrenal parenchyma, and total body activity.

Authors:  F HALBERG; R E PETERSON; R H SILBER
Journal:  Endocrinology       Date:  1959-02       Impact factor: 4.736

2.  Measurement of free corticosteroids in rat plasma: physiological validation of a method.

Authors:  R GUILLEMIN; G W CLAYTON; J D SMITH; H S LIPSCOMB
Journal:  Endocrinology       Date:  1958-09       Impact factor: 4.736

3.  Effect of hormones on lympatic tissue.

Authors:  T F DOUGHERTY
Journal:  Physiol Rev       Date:  1952-10       Impact factor: 37.312

4.  The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats.

Authors:  W L Dewey; T C Peng; L S Harris
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

5.  Delta 9-THC: selective impairment of corticosterone uptake by limbic structures of the rat.

Authors:  W G Drew; D E Slagel
Journal:  Neuropharmacology       Date:  1973-09       Impact factor: 5.250

Review 6.  Fluorimetric analysis of corticoids.

Authors:  R H Silber
Journal:  Methods Biochem Anal       Date:  1966

7.  Corticosterone elevation mediated centrally by delta 1-tetrahydrocannabinol in rats.

Authors:  R K Kubena; J L Perhach; H Barry
Journal:  Eur J Pharmacol       Date:  1971       Impact factor: 4.432

8.  Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism.

Authors:  W D Paton; R G Pertwee
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

9.  Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC).

Authors:  R D Sofia; S D Nalepa; J J Harakal; H B Vassar
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

10.  1-delta9-tetrahydrocannabinol: neurochemical and behavioral effects in the mouse.

Authors:  D Holtzman; R A Lovell; J H Jaffe; D X Freedman
Journal:  Science       Date:  1969-03-28       Impact factor: 47.728

  10 in total
  9 in total

1.  Effects of delta9-tetrahydrocannabinol on the rates of oxygen consumption of mice.

Authors:  R G Pertwee; R Tavendale
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

Review 2.  Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis.

Authors:  Cecilia J Hillard; Margaret Beatka; Jenna Sarvaideo
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

3.  Behavioral and biochemical effects of chronic delta 9-tetrahydrocannabinol in rats.

Authors:  K A Miczek; B N Dixit
Journal:  Psychopharmacology (Berl)       Date:  1980-02       Impact factor: 4.530

4.  Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.

Authors:  Christopher J Roberts; Kara L Stuhr; Michael J Hutz; Hershel Raff; Cecilia J Hillard
Journal:  Pharmacol Biochem Behav       Date:  2013-12-05       Impact factor: 3.533

Review 5.  Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.

Authors:  Matthew N Hill; Patrizia Campolongo; Rachel Yehuda; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2017-07-26       Impact factor: 7.853

6.  Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation.

Authors:  José Antonio López-Moreno; Gustavo González-Cuevas; Fernando Rodríguez de Fonseca; Miguel Navarro
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

7.  Thermoregulatory effects of N6-2'-Q-dibutyryl adenosine 3',5'-monophosphate in the restrained mouse.

Authors:  M J Dascombe; A S Milton; I Nyemitei-Addo; R G Pertwee
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

8.  Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol.

Authors:  A G Fitton; R G Pertwee
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

Review 9.  Effects of opioids, cannabinoids, and vanilloids on body temperature.

Authors:  Scott M Rawls; Khalid Benamar
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.